C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer

2018 ◽  
Vol 34 (2) ◽  
pp. 355-363 ◽  
Author(s):  
Kensuke Kudou ◽  
Hiroshi Saeki ◽  
Yuichiro Nakashima ◽  
Tomohiro Kamori ◽  
Tetsuro Kawazoe ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Prognostic Factor ◽  
Esophagogastric Junction ◽  
C Reactive Protein ◽  
Poor Prognostic Factor ◽  
Albumin Ratio ◽  
Reactive Protein

Preoperative high c-reactive protein/albumin ratio is a poor prognostic factor of oral squamous cell carcinoma

2019 ◽  
Vol 15 (19) ◽  
pp. 2277-2286 ◽  
Author(s):  
Qiuju Wang ◽  
Xiaoyu Song ◽  
Yanzhen Zhao ◽  
Qiao He ◽  
Min Shi ◽  
...  
Keyword(s):  
Squamous Cell Carcinoma ◽  
Prognostic Factor ◽  
Oral Squamous Cell Carcinoma ◽  
Cell Carcinoma ◽  
Squamous Cell ◽  
C Reactive Protein ◽  
Poor Prognostic Factor ◽  
Albumin Ratio ◽  
Reactive Protein

C-reactive protein-albumin ratio as a prognostic factor in renal cell carcinoma – A data from multi-institutional study in Japan

2019 ◽  
Vol 37 (11) ◽  
pp. 812.e1-812.e8 ◽  
Author(s):  
Takuya Tsujino ◽  
Kazumasa Komura ◽  
Takeshi Hashimoto ◽  
Ryu Muraoka ◽  
Naoya Satake ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Prognostic Factor ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
C Reactive Protein ◽  
Albumin Ratio ◽  
Reactive Protein

scholarly journals Prognostic role of the pretreatment C-reactive protein/albumin ratio in gastric cancer

Medicine ◽  
2020 ◽  
Vol 99 (10) ◽  
pp. e19362
Author(s):  
Xuanxuan Yang ◽  
Xing Song ◽  
Luo Zhang ◽  
Changping Wu
Keyword(s):  
Gastric Cancer ◽  
C Reactive Protein ◽  
Prognostic Role ◽  
Albumin Ratio ◽  
Reactive Protein

Clinical Burden of C-Reactive Protein/Albumin Ratio before Curative Surgery for Gastric Cancer Patients

2017 ◽  
Vol 225 (4) ◽  
pp. S187
Author(s):  
Yuji Toiyama ◽  
Yasuhiko Mohri ◽  
Tadanobu Shimura ◽  
Hiromi Yasuda ◽  
Hiroyuki Fujikawa ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Patients ◽  
C Reactive Protein ◽  
Curative Surgery ◽  
Albumin Ratio ◽  
Reactive Protein ◽  
Clinical Burden ◽  
Gastric Cancer Patients

C-reactive protein as an independent prognostic factor for metastatic gastric cancer.

2013 ◽  
Vol 31 (4_suppl) ◽  
pp. 110-110 ◽  
Author(s):  
Mika Kitagawa ◽  
Takaya Shimura ◽  
Tomonori Yamada ◽  
Keisuke Itoh ◽  
Chihiro Hasegawa ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Prognostic Factor ◽  
Progression Free Survival ◽  
Metastatic Gastric Cancer ◽  
Independent Prognostic Factor ◽  
C Reactive Protein ◽  
Antitumor Effects ◽  
Eligibility Criteria ◽  
Reactive Protein ◽  
Serum Crp

110 Background: S-1 plus cisplatin has been recognized as the standard chemotherapy for metastatic gastric cancer (MGC). Inflammation is considered to be a critical component of tumor progression. C-reactive protein (CRP) has been associated with the development of many cancers, but the significance of CRP remains unclear for MGC. The present study assessed the relationship between serum levels CRP and antitumor effects in MGC. Methods: Among 109 MGC patients who received S-1 plus cisplatin as first-line chemotherapy from January 2006 to December 2011 in 3 Japanese institutions, we retrospectively identified 70 patients who fulfilled eligibility criteria of this study. Patients were categorized into 2 groups depending on serum CRP level before chemotherapy: 43 patients with CRP <1.0 mg/dl (CRP <1.0 group) and 27 patients with CRP ≥1.0 mg/dl (CRP ≥1.0 group). Results: Median overall survival was significantly shorter in the CRP ≥1.0 group than in the CRP <1.0 group [267 days (95% CI, 208 to 326) versus 416 days (95% CI, 325 to 507); p = 0.0007]. Moreover, progression-free survival (PFS) was significantly shorter in the CRP ≥1.0 group than in the CRP <1.0 group (median PFS 126 days [95% CI, 63 to 189) versus 188 days (95% CI, 159 to 217); p = 0.0050]. Meanwhile, response rate was determined in 58 patients with target lesions. No significant differences were noted between the CRP <1.0 group and the CRP ≥1.0 group (10/33, 30.3% versus 7/25, 28.0%; p = 0.663). In a multivariate analysis, serum CRP level before chemotherapy was an only independent prognostic factor for MGC (hazard ratio 3.09 (95% CI, 1.46 to 6.54); p = 0.003). Conclusions: Serum CRP level before chemotherapy might be an independent and potential prognostic factor for MGC. Stringent follow-up during chemotherapy is expected for patients with MGC and a high CRP level.

C-Reactive Protein to Albumin Ratio: A Reliable Marker in Gastric Cancer Surgery

2020 ◽  
Author(s):  
Ozlem Zeliha Sert ◽  
Hilmi Bozkurt ◽  
Ibrahim Can Bulut ◽  
Orhan Uzun ◽  
Selcuk Gulmez ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Cancer Surgery ◽  
C Reactive Protein ◽  
Albumin Ratio ◽  
Gastric Cancer Surgery ◽  
Reactive Protein ◽  
Reliable Marker

scholarly journals Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer

2015 ◽  
Vol 8 (4) ◽  
pp. 339-345 ◽  
Author(s):  
Xuechao Liu ◽  
Xiaowei Sun ◽  
Jianjun Liu ◽  
Pengfei Kong ◽  
Shangxiang Chen ◽  
...  
Keyword(s):  
Gastric Cancer ◽  
Curative Resection ◽  
C Reactive Protein ◽  
Albumin Ratio ◽  
Reactive Protein
Sign in / Sign up

Export Citation Format

Share Document